Over the last 12 months, PanCAN stood in strong opposition to the administration’s threats to severely reduce federal funding ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...
In the coming year, more people than ever before are expected to be diagnosed with pancreatic cancer. And with a five-year survival rate that continues to hover at 13%, this cancer remains one of the ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
This Pancreatic Cancer Awareness Month, PanCAN is inviting you to shine a light on pancreatic cancer. Let’s uplift survivors and those living with the disease, honor the lives we’ve lost and help ...
Recently, representing PanCAN Patient Services as our manager of research and education communication, I joined a group of patient advocates and researchers in Cambridge, UK, for an annual symposium ...
A diagnosis of pancreatic cancer can be challenging to navigate – when loved ones step in to provide help in ways large and small it can be a welcome relief. But sometimes a friend, acquaintance or ...
Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...
Editor’s Note: PanCAN volunteers devote their time, energy and passion year-round to improving the lives of everyone impacted by pancreatic cancer. To celebrate Volunteer Appreciation Week 2025 (April ...
The U.S. Food & Drug Administration has granted approval for a new drug to treat pancreatic neuroendocrine tumors, also called PNET or PanNET. “I am delighted that patients with pancreatic ...
Cancer advocates, researchers, clinicians and patients are speaking out in a new STAT News article published this week about the devastating impact the cuts to federal research funding will have on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results